IGC Pharma, Inc. - stock earnings
IGC Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -5.6 million USD | 204000 USD |
2023Q3 | -2.5 million USD | 291000 USD |
2023Q2 | -4.0 million USD | 166000 USD |
2023Q1 | -4.0 million USD | 166000 USD |
2022Q4 | -2.2 million USD | 332000 USD |
2022Q3 | -2.4 million USD | 202000 USD |
2022Q2 | -2.8 million USD | 212000 USD |
2022Q1 | -6.5 million USD | 122000 USD |
2021Q4 | -2.4 million USD | 142000 USD |
2021Q3 | -4.3 million USD | 56000 USD |
2021Q2 | -1.8 million USD | 77000 USD |
2021Q1 | -2.9 million USD | 81000 USD |
2020Q4 | -2.3 million USD | 108000 USD |
2020Q3 | -1.7 million USD | 125000 USD |
2020Q2 | -3.2 million USD | 29000 USD |
2020Q1 | -3.2 million USD | 29000 USD |
2019Q4 | -1.6 million USD | 573000 USD |
2019Q3 | -1.2 million USD | 1.8 million USD |
2019Q2 | -1.4 million USD | 1.6 million USD |
2019Q1 | -1.6 million USD | 1.5 million USD |
2018Q4 | -1.1 million USD | 1.3 million USD |
2018Q3 | -858000 USD | 811000 USD |
2018Q2 | -512296 USD | 1.5 million USD |
2018Q1 | -575283 USD | 1.1 million USD |
2017Q4 | -532581 USD | 762009 USD |
2017Q3 | -303804 USD | 235648 USD |
2017Q2 | -757260 USD | 93372 USD |
2017Q1 | -757260 USD | 93372 USD |
2016Q4 | -111000 USD | 250000 USD |
2016Q3 | -583871 USD | 162163 USD |
2016Q2 | -1.4 million USD | 1.4 million USD |
2016Q1 | -1.4 million USD | 1.4 million USD |
2015Q4 | -402684 USD | 1.1 million USD |
2015Q3 | -623373 USD | 2.1 million USD |
2015Q2 | -1.9 million USD | 2.3 million USD |
2015Q1 | -1.9 million USD | 2.3 million USD |
2014Q4 | -590114 USD | 2.5 million USD |
2014Q3 | -887399 USD | 2.1 million USD |
2014Q2 | -1.5 million USD | -1863 USD |
2014Q1 | -1.5 million USD | -1863 USD |
2013Q4 | -310476 USD | 17529 USD |
2013Q3 | -615187 USD | 1.1 million USD |
2013Q2 | -1.9 million USD | 1.5 million USD |
2013Q1 | -1.9 million USD | 1.5 million USD |
2012Q4 | 310892 USD | 3.9 million USD |
2012Q3 | -142708 USD | 1.4 million USD |
2012Q2 | -4.2 million USD | 1.2 million USD |
2012Q1 | -4.2 million USD | 1.2 million USD |
2011Q4 | -1.9 million USD | 986799 USD |
2011Q3 | -789253 USD | 912121 USD |
2011Q2 | -17.0 million USD | 779816 USD |
2011Q1 | -17.0 million USD | 779816 USD |
2010Q4 | -1.7 million USD | 484106 USD |
2010Q3 | -856260 USD | 1.7 million USD |
2010Q2 | 2.5 million USD | 3.9 million USD |
2010Q1 | 2.5 million USD | 3.9 million USD |
2009Q4 | -6.2 million USD | 5.9 million USD |
2009Q3 | -580192 USD | 5.4 million USD |
2009Q2 | -146741 USD | 3.1 million USD |
2009Q1 | -146741 USD | 3.1 million USD |
2008Q4 | -1.7 million USD | 3.8 million USD |
2008Q3 | 72425 USD | 10.5 million USD |
2008Q2 | -5.1 million USD | 17.9 million USD |
2008Q1 | -5.1 million USD | ? USD |
2007Q4 | -125582 USD | -286006 USD |
2007Q3 | 11048 USD | -204684 USD |
2007Q2 | 326806 USD | -179844 USD |
2007Q1 | 326806 USD | ? USD |
2006Q4 | 344036 USD | ? USD |
2006Q3 | 414767 USD | ? USD |
2006Q2 | 432388 USD | ? USD |
2006Q1 | 122420 USD | ? USD |
2005Q4 | -15184 USD | ? USD |
2005Q2 | -15000 USD | ? USD |
IGC Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -11.4 million USD | 911000 USD |
2022 | -14.6 million USD | 397000 USD |
2021 | -9.0 million USD | 898000 USD |
2020 | -8.1 million USD | 4.1 million USD |
2019 | -4.1 million USD | 5.1 million USD |
2018 | -1.8 million USD | 2.2 million USD |
2017 | -1.9 million USD | 580372 USD |
2016 | -2.8 million USD | 6.4 million USD |
2015 | -4.6 million USD | 7.7 million USD |
2014 | -3.0 million USD | 2.3 million USD |
2013 | -2.3 million USD | 8.0 million USD |
2012 | -7.8 million USD | 4.2 million USD |
2011 | -20.2 million USD | 4.1 million USD |
2010 | -4.8 million USD | 17.9 million USD |
2009 | -521576 USD | 35.3 million USD |
2008 | -5.2 million USD | 2.2 million USD |
2007 | 1.5 million USD | -765047 USD |
2006 | 91901 USD | 210584 USD |
IGC
Price: $0.56
52 week price:
Earnings Per Share: -0.26 USD
P/E Ratio: -1.43
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 122069
Market Capitalization: 40.8 million